Live from the NIH registry
Studies recruiting near Galveston right now
Top 25 of 200 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Phase 1
Interventional 42 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: Pfizer
Improving Sleep In Midlife Women
Poor Sleep Quality
N/A
Interventional 72 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Texas Oncology Gulf Coast — Webster, Texas (24.2 mi)
· Sponsor: Immuneering Corporation
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: SWOG Cancer Research Network
Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.
Contrast-induced Acute Kidney Injury (CI-AKI) Following Coronary Angiogram (CI-AKI), Contrast-induced Nephropathy Following Coronary Angiogram (CIN)
N/A
Interventional 300 participants sought
University of Texas- Medical Branch (UTMB) — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
Preterm Premature Rupture of Membrane, Pregnancy, High Risk
Phase 4
Interventional 56 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Ohio State University
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Friendswood, Texas (26.9 mi)
· Sponsor: Axsome Therapeutics, Inc.
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
Spinal Cord Injuries, Urinary Incontinence
Phase 2
Interventional 24 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Oropharyngeal Cancer
Phase 3
Interventional 510 participants sought
UT MD Anderson - League City — League City, Texas (21.7 mi)
· Sponsor: Canadian Cancer Trials Group
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Phase 3
Interventional 600 participants sought
Investigative Site US068 — Webster, Texas (24.2 mi)
· Sponsor: Incyte Corporation
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Phase 1
Interventional 80 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Webster, Texas (24.2 mi)
· Sponsor: Akero Therapeutics, Inc
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Webster, Texas (24.2 mi)
· Sponsor: Xencor, Inc.
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Colorectal Cancer
Phase 2
Interventional 90 participants sought
The University of Texas MD Anderson Cancer Center — Texas City, Texas (9.4 mi)
· Sponsor: Kahr Bio Australia Pty Ltd
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)
Phase 2
Interventional 140 participants sought
Mirador Therapeutics Selected Site — Webster, Texas (24.2 mi)
· Sponsor: Mirador Therapeutics, Inc.
Tirzepatide to Slow Biological Aging
Aging, LONGEVITY 1
Phase 2
Interventional 90 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Galveston — Galveston, Texas (6.7 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Novo Nordisk A/S
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
NSCLC Stage II, NSCLC, Stage III
N/A
Interventional 20 participants sought
University of Texas Medical Branch at Galveston — Galveston, Texas (6.7 mi)
· Sponsor: University of Utah
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Breast Ductal Carcinoma In Situ, COVID-19 Infection
N/A
Observational 600 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: M.D. Anderson Cancer Center
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
UT MD Anderson - League City — League City, Texas (21.7 mi)
· Sponsor: NRG Oncology
Brain Stimulation Enhance Post-stroke Walking Survivors and Healthy Adults
Cerebral Vascular Accident
N/A
Interventional 70 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
University of Texas Medical Branch at Galveston — Galveston, Texas (6.7 mi)
· Sponsor: Boehringer Ingelheim